Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Showing 1 to 12 of 59 entries
Sorted by: Best Match Show Resources per page
[Bonferroni-Holm sequential test procedure].

Zeitschrift fur Gastroenterologie

Sonnenberg A.
PMID: 4090570
Z Gastroenterol. 1985 Dec;23(12):703-4.

No abstract available.

Methods of estimation of IC50 and SC50 parameters for indirect response models from single dose data.

Journal of pharmaceutical sciences

Wyska E, Mager DE, Krzyzanski W.
PMID: 12820148
J Pharm Sci. 2003 Jul;92(7):1438-54. doi: 10.1002/jps.10407.

The basic indirect response models are described by several pharmacodynamic parameters of which IC(50) (drug concentration eliciting 50% of the maximum inhibition) and SC(50) (drug concentration eliciting 50% of the maximum stimulation) are not readily derived from the response...

Concentration-effect and dose-response relations in clinical pharmacology.

British journal of clinical pharmacology

Aronson JK.
PMID: 17311674
Br J Clin Pharmacol. 2007 Mar;63(3):255-7. doi: 10.1111/j.1365-2125.2007.02871.x.

No abstract available.

Tripartite meeting. Paediatric regulatory guidelines: do they help in optimizing dose selection for children?.

British journal of clinical pharmacology

Baber NS.
PMID: 15948928
Br J Clin Pharmacol. 2005 Jun;59(6):660-2. doi: 10.1111/j.1365-2125.2005.02427.x.

No abstract available.

Correct date for Paracelsus.

The American journal of clinical nutrition

Colombani P.
PMID: 16332673
Am J Clin Nutr. 2005 Dec;82(6):1357. doi: 10.1093/ajcn/82.6.1357.

No abstract available.

Quick lessons on environmental nanotech.

Nature nanotechnology

Toumey C.
PMID: 26139139
Nat Nanotechnol. 2015 Jul;10(7):566-7. doi: 10.1038/nnano.2015.144.

No abstract available.

Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development.

Clinical and translational science

Burt T, Yoshida K, Lappin G, Vuong L, John C, de Wildt SN, Sugiyama Y, Rowland M.
PMID: 26918865
Clin Transl Sci. 2016 Apr;9(2):74-88. doi: 10.1111/cts.12390. Epub 2016 Mar 30.

A number of drivers and developments suggest that microdosing and other phase 0 applications will experience increased utilization in the near-to-medium future. Increasing costs of drug development and ethical concerns about the risks of exposing humans and animals to...

[Application of nonlinear regression model to sigmoid dose-response relationship in pharmacological studies].

Nihon yakurigaku zasshi. Folia pharmacologica Japonica

Sakiyama Y, Ohashi K, Takahashi Y.
PMID: 18854620
Nihon Yakurigaku Zasshi. 2008 Oct;132(4):199-206. doi: 10.1254/fpj.132.199.

No abstract available.

An examination of the Environmental Protection Agency risk assessment principles and practices: a brief commentary on section 4.1.3 of the EPA March 2004 Staff Paper.

Human & experimental toxicology

Mundt KA.
PMID: 16459710
Hum Exp Toxicol. 2006 Jan;25(1):19-21. doi: 10.1191/0960327106ht580oa.

The US Environmental Protection Agency (EPA) recently issued a Staff Paper that articulates current risk assessment practices. In section 4.1.3, EPA states, "... effects that appear to be adaptive, non-adverse, or beneficial may not be mentioned." This statement may...

Proof of concept and dose estimation with binary responses under model uncertainty.

Statistics in medicine

Klingenberg B.
PMID: 19012269
Stat Med. 2009 Jan 30;28(2):274-92. doi: 10.1002/sim.3477.

This article suggests a unified framework for testing Proof of Concept (PoC) and estimating a target dose for the benefit of a more comprehensive, robust and powerful analysis in phase II or similar clinical trials. From a pre-specified set...

Design of experiments for the precise estimation of dose-response parameters: the Hill equation.

Journal of theoretical biology

Bezeau M, Endrenyi L.
PMID: 3657186
J Theor Biol. 1986 Dec 21;123(4):415-30. doi: 10.1016/s0022-5193(86)80211-9.

Optimal experimental designs were evaluated for the precise estimation of parameters of the Hill model. The optimally effective designs were obtained by using the criterion of D-optimization. For the Hill model, optimal designs replicate 3 sampling points. These points...

Is it possible to estimate the parameters of the sigmoid Emax model with truncated data typical of clinical studies?.

Journal of pharmaceutical sciences

Dutta S, Matsumoto Y, Ebling WF.
PMID: 8683454
J Pharm Sci. 1996 Feb;85(2):232-9. doi: 10.1021/js950067y.

Many drug concentration-effect relationships are described by the nonlinear sigmoid E(max) model. Clinical considerations frequently limit the magnitude of effect intensity that may be produced; the most pronounced effect intensity may be considerably below E(max). We have tested and...

Showing 1 to 12 of 59 entries